BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Horwitz BJ, Fisher RS. The irritable bowel syndrome. N Engl J Med. 2001;344:1846-1850. [PMID: 11407347 DOI: 10.1056/nejm200106143442407] [Cited by in Crossref: 135] [Cited by in F6Publishing: 32] [Article Influence: 6.4] [Reference Citation Analysis]
Number Citing Articles
1 Cho SY, Park S, Lee SB, Paick J, Son H. Do Effects on Bowel Patterns Imposed by Solifenacin Always Have Negative Impacts on Treating Patients with Overactive Bladder (OAB)?: Effect of Solifenacin on Bowel. Lower Urinary Tract Symptoms 2016;8:106-12. [DOI: 10.1111/luts.12081] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
2 Chai Y, Huang Y, Tang H, Tu X, He J, Wang T, Zhang Q, Xiong F, Li D, Qiu Z. Role of stem cell growth factor/c-Kit in the pathogenesis of irritable bowel syndrome. Exp Ther Med 2017;13:1187-93. [PMID: 28413456 DOI: 10.3892/etm.2017.4133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kang JM. Neuropeptide s receptor induces neuropeptide expression and associates with intermediate phenotypes of functional gastrointestinal disorders (gastroenterology 2010;138:98-107). J Neurogastroenterol Motil 2010;16:218-20. [PMID: 20535358 DOI: 10.5056/jnm.2010.16.2.218] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
4 Ramos L, Vicario M, Santos J. [Stress-mast cell axis and regulation of gut mucosal inflammation: from intestinal health to an irritable bowel]. Med Clin (Barc) 2007;129:61-9. [PMID: 17588364 DOI: 10.1157/13106939] [Reference Citation Analysis]
5 Khaldi S, Gargala G, Le Goff L, Parey S, Francois A, Fioramonti J, Ballet JJ, Dupont JP, Ducrotté P, Favennec L. Cryptosporidium parvum isolate-dependent postinfectious jejunal hypersensitivity and mast cell accumulation in an immunocompetent rat model. Infect Immun 2009;77:5163-9. [PMID: 19687199 DOI: 10.1128/IAI.00220-09] [Cited by in Crossref: 17] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
6 Friedt M. Reizdarmsyndrom. Monatsschr Kinderheilkd 2008;156:275-86. [DOI: 10.1007/s00112-008-1696-9] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
7 Meydan C, Afshinnekoo E, Rickard N, Daniels G, Kunces L, Hardy T, Lili L, Pesce S, Jacobson P, Mason CE, Dudley J, Zhang B. Improved gastrointestinal health for irritable bowel syndrome with metagenome-guided interventions. Precis Clin Med 2020;3:136-46. [PMID: 32685241 DOI: 10.1093/pcmedi/pbaa013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
8 Marsh A, Eslick EM, Eslick GD. Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta-analysis. Eur J Nutr 2016;55:897-906. [DOI: 10.1007/s00394-015-0922-1] [Cited by in Crossref: 179] [Cited by in F6Publishing: 147] [Article Influence: 25.6] [Reference Citation Analysis]
9 Yamazawa T, Iino M. Simultaneous imaging of Ca2+ signals in interstitial cells of Cajal and longitudinal smooth muscle cells during rhythmic activity in mouse ileum. J Physiol 2002;538:823-35. [PMID: 11826167 DOI: 10.1113/jphysiol.2001.013045] [Cited by in Crossref: 62] [Cited by in F6Publishing: 60] [Article Influence: 3.1] [Reference Citation Analysis]
10 AlButaysh OF, AlQuraini AA, Almukhaitah AA, Alahmdi YM, Alharbi FS. Epidemiology of irritable bowel syndrome and its associated factors in Saudi undergraduate students. Saudi J Gastroenterol 2020;26:89-93. [PMID: 32031159 DOI: 10.4103/sjg.SJG_459_19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Longstreth GF, Drossman DA. New developments in the diagnosis and treatment of irritable bowel syndrome. Curr Gastroenterol Rep 2002;4:427-34. [PMID: 12228046 DOI: 10.1007/s11894-002-0014-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
12 Fiderkiewicz B, Rydzewska-Rosołowska A, Myśliwiec M, Birecka M, Kaczanowska B, Rydzewska G, Rydzewski A. Factors associated with irritable bowel syndrome symptoms in hemodialysis patients. World J Gastroenterol 2011; 17(15): 1976-1981 [PMID: 21528075 DOI: 10.3748/wjg.v17.i15.1976] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
13 Portincasa P, Moschetta A, Baldassarre G, Altomare DF, Palasciano G. Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndrome. World J Gastroenterol 2003; 9(10): 2293-2299 [PMID: 14562396 DOI: 10.3748/wjg.v9.i10.2293] [Cited by in CrossRef: 55] [Cited by in F6Publishing: 63] [Article Influence: 2.9] [Reference Citation Analysis]
14 Cole JA, Yeaw JM, Cutone JA, Kuo B, Huang Z, Earnest DL, Walker AM. The incidence of abdominal and pelvic surgery among patients with irritable bowel syndrome. Dig Dis Sci 2005;50:2268-75. [PMID: 16416174 DOI: 10.1007/s10620-005-3047-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
15 Yale SH, Musana AK, Kieke A, Hayes J, Glurich I, Chyou PH. Applying case definition criteria to irritable bowel syndrome. Clin Med Res 2008;6:9-16. [PMID: 18591372 DOI: 10.3121/cmr.2008.788] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
16 Santonicola A, Siniscalchi M, Capone P, Gallotta S, Ciacci C, Iovino P. Prevalence of functional dyspepsia and its subgroups in patients with eating disorders. World J Gastroenterol 2012; 18(32): 4379-4385 [PMID: 22969202 DOI: 10.3748/wjg.v18.i32.4379] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
17 Cearley SM, Immaneni S, Shankar P. Irritable Bowel Syndrome: The effect of FODMAPs and meditation on pain management. European Journal of Integrative Medicine 2017;12:117-21. [DOI: 10.1016/j.eujim.2017.05.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
18 Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 2006;6:26. [PMID: 17007634 DOI: 10.1186/1471-230x-6-26] [Cited by in Crossref: 94] [Cited by in F6Publishing: 41] [Article Influence: 5.9] [Reference Citation Analysis]
19 Ladep NG, Obindo TJ, Audu MD, Okeke EN, Malu AO. Depression in patients with irritable bowel syndrome in Jos, Nigeria. World J Gastroenterol 2006; 12(48): 7844-7847 [PMID: 17203531 DOI: 10.3748/wjg.v12.i48.7844] [Cited by in CrossRef: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.5] [Reference Citation Analysis]
20 Smith RC, Dwamena FC. Classification and diagnosis of patients with medically unexplained symptoms. J Gen Intern Med 2007;22:685-91. [PMID: 17443380 DOI: 10.1007/s11606-006-0067-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 55] [Article Influence: 4.8] [Reference Citation Analysis]
21 Strege PR, Sha L, Beyder A, Bernard CE, Perez-Reyes E, Evangelista S, Gibbons SJ, Szurszewski JH, Farrugia G. T-type Ca(2+) channel modulation by otilonium bromide. Am J Physiol Gastrointest Liver Physiol 2010;298:G706-13. [PMID: 20203058 DOI: 10.1152/ajpgi.00437.2009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
22 Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Incidence of IBS in a cohort of people with asthma. Dig Dis Sci. 2007;52:329-335. [PMID: 17211701 DOI: 10.1007/s10620-006-9530-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
23 Saha L. Irritable bowel syndrome: Pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol 2014; 20(22): 6759-6773 [PMID: 24944467 DOI: 10.3748/wjg.v20.i22.6759] [Cited by in CrossRef: 131] [Cited by in F6Publishing: 111] [Article Influence: 16.4] [Reference Citation Analysis]
24 Occhipinti K, Smith JW. Irritable bowel syndrome: a review and update. Clin Colon Rectal Surg. 2012;25:46-52. [PMID: 23449495 DOI: 10.1055/s-0032-1301759] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
25 Cremonini F, Camilleri M, Clark MM, Beebe TJ, Locke GR, Zinsmeister AR, Herrick LM, Talley NJ. Associations among binge eating behavior patterns and gastrointestinal symptoms: a population-based study. Int J Obes (Lond). 2009;33:342-353. [PMID: 19139750 DOI: 10.1038/ijo.2008.272] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 3.5] [Reference Citation Analysis]
26 Porter CK, Cash BD, Pimentel M, Akinseye A, Riddle MS. Risk of inflammatory bowel disease following a diagnosis of irritable bowel syndrome. BMC Gastroenterol. 2012;12:55. [PMID: 22639930 DOI: 10.1186/1471-230x-12-55] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
27 Tasci I, Gulsun M. Panic Attack Precipitated by Tegaserod plus Fluoxetine. Clin Drug Investig 2005;25:355-7. [PMID: 17532675 DOI: 10.2165/00044011-200525050-00010] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
28 Zipser RD, Patel S, Yahya KZ, Baisch DW, Monarch E. Presentations of adult celiac disease in a nationwide patient support group. Dig Dis Sci 2003;48:761-4. [PMID: 12741468 DOI: 10.1023/a:1022897028030] [Cited by in Crossref: 76] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
29 Nygaard I, Shaw J, Egger MJ. Exploring the association between lifetime physical activity and pelvic floor disorders: study and design challenges. Contemp Clin Trials 2012;33:819-27. [PMID: 22521947 DOI: 10.1016/j.cct.2012.04.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
30 Park DW, Lee OY, Shim SG, Jun DW, Lee KN, Kim HY, Lee HL, Yoon BC, Choi HS. The Differences in Prevalence and Sociodemographic Characteristics of Irritable Bowel Syndrome According to Rome II and Rome III. J Neurogastroenterol Motil. 2010;16:186-193. [PMID: 20535350 DOI: 10.5056/jnm.2010.16.2.186] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
31 Daghaghzadeh H, Memar A, Mohamadi Y, Rezakhani N, Safazadeh P, Aghaha S, Adibi P. Therapeutic Effects of Low-dose Bismuth Subcitrate on Symptoms and Health-related Quality of Life in Adult Patients with Irritable Bowel Syndrome: A Clinical Trial. J Res Pharm Pract 2018;7:13-21. [PMID: 29755994 DOI: 10.4103/jrpp.JRPP_17_56] [Reference Citation Analysis]
32 Qureshi SR, Abdelaal AM, Janjua ZA, Alasmari HA, Obad AS, Alamodi A, Shareef MA. Irritable Bowel Syndrome: A Global Challenge Among Medical Students. Cureus 2016;8:e721. [PMID: 27625907 DOI: 10.7759/cureus.721] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
33 Britton RA, Versalovic J. Probiotics and gastrointestinal infections. Interdiscip Perspect Infect Dis 2008;2008:290769. [PMID: 19277100 DOI: 10.1155/2008/290769] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
34 Guilarte M, Santos J, de Torres I, Alonso C, Vicario M, Ramos L, Martínez C, Casellas F, Saperas E, Malagelada JR. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut. 2007;56:203-209. [PMID: 17005763 DOI: 10.1136/gut.2006.100594] [Cited by in Crossref: 255] [Cited by in F6Publishing: 243] [Article Influence: 15.9] [Reference Citation Analysis]
35 Lembo A, Weber HC, Farraye FA. Alosetron in irritable bowel syndrome: strategies for its use in a common gastrointestinal disorder. Drugs. 2003;63:1895-1905. [PMID: 12930162 DOI: 10.2165/00003495-200363180-00002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
36 Altobelli E, Del Negro V, Angeletti PM, Latella G. Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients. 2017;9. [PMID: 28846594 DOI: 10.3390/nu9090940] [Cited by in Crossref: 82] [Cited by in F6Publishing: 61] [Article Influence: 16.4] [Reference Citation Analysis]
37 Soares RL. Irritable bowel syndrome: A clinical review. World J Gastroenterol 2014; 20(34): 12144-12160 [PMID: 25232249 DOI: 10.3748/wjg.v20.i34.12144] [Cited by in CrossRef: 94] [Cited by in F6Publishing: 83] [Article Influence: 11.8] [Reference Citation Analysis]
38 Valdez-Palomares F, Nambo-Venegas R, Uribe-García J, Mendoza-Vargas A, Granados-Portillo O, Meraz-Cruz N, Palacios-González B. Intestinal microbiota fingerprint in subjects with irritable bowel syndrome responders to a low FODMAP diet. Food Funct 2021;12:3206-18. [PMID: 33877245 DOI: 10.1039/d0fo03162c] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Reina J, Smith JW. Medical treatment of irritable bowel syndrome. Clin Colon Rectal Surg 2005;18:102-8. [PMID: 20011349 DOI: 10.1055/s-2005-870891] [Reference Citation Analysis]
40 Iorio N, Malik Z, Schey R. Profile of rifaximin and its potential in the treatment of irritable bowel syndrome. Clin Exp Gastroenterol 2015;8:159-67. [PMID: 26089696 DOI: 10.2147/CEG.S67231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
41 Elhosseiny D, Mahmoud NE, Manzour AF. Factors associated with irritable bowel syndrome among medical students at Ain Shams University. J Egypt Public Health Assoc 2019;94:23. [PMID: 32813140 DOI: 10.1186/s42506-019-0023-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]